search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Test & measurement


Helping to build life-changing exoskeletons


RLS magnetic encoders are enabling Marsi Bionics to design and build exoskeleton orthopaedic devices that could improve the quality of life for people suffering from diseases such as spinal muscular atrophy, multiple sclerosis, and hemiplegia caused by stroke


M


arsi Bionics is a leading technology start-up based in Madrid, Spain. It designs and builds custom exoskeletons


for medical applications with the aim of potentially replacing the wheelchair in everyday life for some patients. Millions of people suffer from debilitating neurophysical conditions such as paraplegia, cerebral palsy and spinal muscular atrophy (SMA). Neurological rehabilitation with passive aids such as canes, crutches and walkers is vital in the treatment of mobility issues caused by these conditions. Recent advances in robotics have allowed treatment with powered (active) robot exoskeletons that support the patient's body and enable greatly improved outcomes. The exoskeletons, created by Marsi Bionics, give


physically disabled people the freedom to stand, move and interact with their environment. Data collected from the encoders is fundamental for generating the position references. RLS and Renishaw provided Marsi Bionies with the best encoder feedback solutions for its applications. RLS, a Renishaw associate company, has been chosen by Marsi Bionics to supply the latest in magnetic encoder technology for the creation of two new products: the ATLAS 2030 exoskeleton for children and the MB-Active Knee (MAK) single-joint exoskeleton for adults.


54


THE CHALLENGE The ATLAS 2030 exoskeleton has up to six degrees of freedom per limb. This device enables the user to perform both unaided and self- actuated actions such as walking and sitting. Full exoskeletons consist of motorised joints, limbs, electronic control and power systems. The designer must find a compromise between


a lightweight and compact structure that facilitates easy handling by the user, who might be physically weakened, and a robotic system that implements a physiologically complete biomechanical model. For stable walking, equilibrium control of the


exoskeleton-user assembly is achieved by tracking its zero-moment point (ZMP) references, which are based on the desired Normalised Dynamic Stability Margin (NDSM). The exoskeleton’s controller can subsequently adapt reference walking gait patterns, stored in memory, to maintain stability.


Successful dynamic walking requires precise control of the legs’ joint angles in terms of position, velocity and acceleration via rotary encoder feedback. This is difficult to achieve as each mechanical joint is compliant and includes elastic elements to help mimic and support the real joints and muscles of the human user. Alberto Plaza, R&D engineer and manager of the MAK project at Marsi Bionics, describes


the stringent encoder requirements of human exoskeletons: “The most difficult challenge when developing exoskeletons is the reliability of obtaining accurate angular position references, as they change from one structure to another, complicating standardisation and assembly of the devices.


September 2020 Instrumentation Monthly


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78